Clinical trial
Individualizing Automated Closed Loop Glucose Control Through Pharmacokinetic Profiling in an Insulin-Only Bionic Pancreas
NCT03262116
Study timeline
Study start (actual)2019-03-19Date precision: day
Registry last updated2022-12-09
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Type 1 Diabetes Mellitusunresolved
Interventions
HumalogDRUG · verified · RxNorm: Humalog
NovologDRUG · verified · RxNorm: NovoLog
Bionic PancreasDEVICE
Sponsors & collaborators
Massachusetts General Hospitallead sponsor
Boston Universitycollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03262116 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.